Critical Survey: Arcturis Data (OTCMKTS:SSYNF) & OptimizeRx (NASDAQ:OPRX)

OptimizeRx (NASDAQ:OPRXGet Free Report) and Arcturis Data (OTCMKTS:SSYNFGet Free Report) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, dividends, risk, institutional ownership and valuation.

Profitability

This table compares OptimizeRx and Arcturis Data’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
OptimizeRx 4.66% 9.44% 7.11%
Arcturis Data N/A N/A N/A

Analyst Recommendations

This is a breakdown of recent recommendations for OptimizeRx and Arcturis Data, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OptimizeRx 1 2 6 0 2.56
Arcturis Data 0 0 0 0 0.00

OptimizeRx presently has a consensus price target of $11.43, indicating a potential upside of 43.76%. Given OptimizeRx’s stronger consensus rating and higher probable upside, research analysts clearly believe OptimizeRx is more favorable than Arcturis Data.

Valuation and Earnings

This table compares OptimizeRx and Arcturis Data”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
OptimizeRx $98.65 million 1.52 $5.13 million $0.23 34.57
Arcturis Data N/A N/A N/A N/A N/A

OptimizeRx has higher revenue and earnings than Arcturis Data.

Insider and Institutional Ownership

76.5% of OptimizeRx shares are owned by institutional investors. 7.5% of OptimizeRx shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

OptimizeRx beats Arcturis Data on 9 of the 9 factors compared between the two stocks.

About OptimizeRx

(Get Free Report)

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

About Arcturis Data

(Get Free Report)

Arcturis Data Limited, a data company, uses data to support the discovery and development of new medicines. It supports the delivery of research across various phases of the clinical development pipeline covering various conditions and treatment types. The company translates patient pathways to support clinical development, inform policy, and advance research. It collaborates with research and industry experts to create disease-specific datasets. The company was formerly known as Sensyne Health Limited and changed its name to Arcturis Data Limited in October 2022. Arcturis Data Limited was incorporated in 2018 and is based in Kidlington, the United Kingdom.

Receive News & Ratings for OptimizeRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptimizeRx and related companies with MarketBeat.com's FREE daily email newsletter.